Bridgebio Pharma Inc. (BBIO)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Viking Global

Andreas Halvorsen

26,620,991 $1,247,726 3.46%
2.
Perceptive Advisors

Joseph Edelman

7,756,928 $363,567 5.27%
3. 5,362,014 $251,318 3.28%
4. 114,950,000 $158,746 +57% 0.03%
5.
Deerfield ManagementNOTE 2.500% 3/1

James E. Flynn

80,000,000 $110,499 2.15%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$62.50 8,000 Officer 300,043 2021-02-17 Filing
$62.50 16,000 Director 21,000 2021-02-17 Filing
$17.00 2,647,100 Large Shareholder 36,900,661 2019-07-01 Filing
$17.00 14,000 Officer 14,000 2019-07-01 Filing
$17.00 7,000 Officer 180,767 2019-07-01 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$53.23 13,777 Officer, Director 45,860 2021-08-04 Filing
$60.47 3,450,000 31,060,971 2021-02-17 Filing
$69.94 8,563 Officer 12,568 2020-12-28 Filing
$69.34 10,937 Officer 21,131 2020-12-28 Filing
$65.48 45,473 Officer, Director 45,860 2020-12-21 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 70,696 $3,313,521 0%
2. 31,060,971 $1,455,828 7.26%
3. 22,982 $1,077,166 0%
4. 10,141,311 $475,323 0.01%
5. 9,435,412 $442,238 0.01%
News See All